demethoxydaunorubicin ( dmdr ) , a new anthracycline available both for intravenous and oral administration , was given in 14 cases of leukaemia , non-hodgkin 's lymphoma ( nhl ) and multiple myeloma ( mm ) replacing either daunorubicin ( dnr ) or doxorubicin ( dox ) in conventional chemotherapy regimes .
C0011015
daunorubicin
C0013089
doxorubicin